Drugs & Targets Thermo Fisher Scientific’s CE-IVD marked next-gen sequencing instrument available for use in clinical labs April 01, 2022Vol.48 No.13
Drugs & Targets Paige launches AI software to enable accurate and efficient detection of breast cancer metastases in lymph nodes April 01, 2022Vol.48 No.13
Conversation with The Cancer Letter James P. Allison Institute at MD Anderson seeks to refocus immunotherapy research March 25, 2022Vol.48 No.12By Matthew Bin Han Ong and Paul Goldberg
ACS report: “Alarming” health disparities in preventable cancers persist as overall cancer mortality continues to fall March 25, 2022Vol.48 No.12By Alice Tracey
Guest Editorial Single-country clinical trial results: Are they applicable to other populations? March 25, 2022Vol.48 No.12By Edward S. Kim
Guest Editorial War in Ukraine: The nuclear threat increases March 25, 2022Vol.48 No.12By Robert Peter Gale
In Brief Steven Rosenberg receives the 2022 Pezcoller Foundation-AACR International Award March 25, 2022Vol.48 No.12
In Brief Krishna Komanduri named division chief of hematology-oncology at UCSF Health March 25, 2022Vol.48 No.12
